Features of Colon Microbiocenosis and Faecal Calprotectin Level in Patients with Chronic Inflammatory Bowel Diseases Depending on the Nutritional Status
The article deals with an actual problem — the state of the microflora of the colon and faecal calprotectin level in patients with chronic inflammatory bowel diseases with different nutritional status. The study involved 76 patients with chronic inflammatory bowel diseases, including 28 patients with Crohn’s disease and 48 — with ulcerative colitis. We analyzed the findings depending on the nosology and nutritional status. It was found that among the patients of studied groups, patients with subcompensated form of dysbiosis dominated. Reducing the concentration of bifidobacteria in the colon content of patients from group III was detected more often — in 78.9 % of cases. Deficiency of lactobacilli was most often observed in patients of group II (92.3 %). The content of calprotectin was significantly increased in 84.2 % of patients, it positively correlated with the degree of severity of the disease and did not depend on their nutritional status.
Full Text:PDF (Українська)
Adler G., Fiocchi C., Lazebnik L.B., Vorobiev G.I. Inflammatory Bowel Disease diagnostic and therapeutic strategies. − Springer, 2007. − 237 p.
Rumyantsev V.G. Ulcerative colitis: a guide for physicians. - Moscow: Medical News Agency, 2009. − 424 р. (In Russ.)
Kanshin O.A., Kanshin N. Ulcerative colitis in children (and rooted). - M.: Bioinformservis, 2002. − 212 р. (In Russ.)
Gastroenterology: national leadership / under. Ed. V.T. Ivashkina, T.L. Lapina. - M.: GEOTAR Media, 2008. − 704 р. (In Russ.)
Abaturov O.E., Stepanova J.J. Determination of fecal kalprotektyn with rotavirus infection in children. Gastroenterology. 2014; (4): 106-109 (In Russ.).
Stepanov J.M., Fedorova N.S. Contents fecal kalprotektyn in patients with chronic inflammatory bowel disease. Current gastroenterology. 2010; (2): 44-48 (In Russ.).
Tatyanyna O.F., Potapov A.S., Namazova L.S., Cimbalova E.G., Kucherenko A.G., Surkov A.N. Markers intestinal inflammation in the bowel disease: review of literature. Pediatric pharmacology. 2008; (3): 39-45 (In Russ.).
Tatyanyna O.F., Potapov A.S., Namazova L.S., Cimbalova E.G., Kucherenko A.G., Lokhmatov M.M. Fecal calprotectin in the non-invasive diagnosis of inflammatory bowel disease in children. Pediatric pharmacology. 2008; (3): 46-51 (In Russ.).
Dolgih T.I. Fecal calprotectin - a non-invasive biomarker of inflammatory bowel process. Special edition laboratory. 2013; (3): 44-46 (In Russ.).
Roset A.G., Aadland E., Grzyb K. Normalization of faecal calprotectin: a predictor of healing in patients with inflammatory bowel. Scand. University Press. 2004; (9): 1012-1017.
Roseth A.G., Aadland E., Jahnsen J. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion. 1997; (58): 176-180.
Bistrian B. Role of the systemic inflammatory response in the development of protein"energy malnutrition in Inflammatory bowel disease. Inflammatory Bowel Diseases: Nestle Nutrition Workshop Series Clinical & Performance Programme. 1999; (2): 1–6.
Sindeeva L.V., Kazakova G.N. Anthropometry and bioimpedance: parallels and differences. Fundamental research. 2013; (9): 476-480 (In Russ.).
Luft V.M., Tkachenko E.I. Trophological failure and its diagnostic criteries. Military Medical Journal. 1993; (12): 21-24 (In Russ.).
Rocha R., Santana G.O., Almeida N., Lyra A. C. Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase. Br. J. Nutr. 2009; (101): 676-679.
Wang J., Thornton J.C., Kolesnik S., Pierson R.N. Anthropometry in body composition: An overview Ann. N.Y. Acad. Sci. 2000; ( 904): 317–326.
Copyright (c) 2016 GASTROENTEROLOGY
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2019